Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Evaluation of Continuous Symptom Treatment of ADHD: A Placebo-Controlled Double-Blind Assessment of Morning-Dosed or Evening-Dosed Strattera
Atomoxetine
B4Z-US-LYCC
NCT00486122
Attention Deficit Hyperactivity Disorder
Phase 4
 
The annotated case report form is not available. A blank case report form will be provided.
November 2014

Powered by ideaPoint, Inc.